Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome.
- DOI
- 10.1160/th13-07-0543
- Published
- 2014 Jun
- Container
- Thrombosis and haemostasis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1160/th13-07-0543,
title = {Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome.},
author = {Goldstein S and Bates ER and Bhatt DL and Cao C and Holmes D and Kupfer S and Martinez F and Spaeder J and Weitz JI and Ye Z and Zannad F and AXIOM investigators},
year = {2014},
journal = {Thrombosis and haemostasis},
doi = {10.1160/th13-07-0543},
url = {https://doi.org/10.1160/th13-07-0543}
}RIS
TY - JOUR TI - Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome. AU - Goldstein S AU - Bates ER AU - Bhatt DL AU - Cao C AU - Holmes D AU - Kupfer S AU - Martinez F AU - Spaeder J AU - Weitz JI AU - Ye Z AU - Zannad F AU - AXIOM investigators PY - 2014 JO - Thrombosis and haemostasis DO - 10.1160/th13-07-0543 UR - https://doi.org/10.1160/th13-07-0543 ER -
APA
S, G., ER, B., DL, B., C, C., D, H., S, K., F, M., J, S., JI, W., Z, Y., F, Z., & investigators, A. (2014). Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome.. Thrombosis and haemostasis. https://doi.org/10.1160/th13-07-0543
Source records
- pubmed · retrieved 2026-09-26T15:09:34.249Z